Eileen Z. Zhang

Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3·4A Protease Inhibitors in Treatment‐Naive Subjects

Doug J. Bartels, Yi Zhou, Eileen Z. Zhang et al. · The Journal of Infectious Diseases · 2008 · 207 citations

Medicine, Infectious Diseases, Pharmacology +17

Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials

James C. Sullivan, Sandra De Meyer, Doug J. Bartels et al. · Clinical Infectious Diseases · 2013 · 165 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Hepatitis C Virus Variants with Decreased Sensitivity to Direct-Acting Antivirals (DAAs) Were Rarely Observed in DAA-Naive Patients prior to Treatment

Doug J. Bartels, James C. Sullivan, Eileen Z. Zhang et al. · Journal of Virology · 2012 · 144 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials

Tara L. Kieffer, Sandra De Meyer, Doug J. Bartels et al. · PLoS ONE · 2012 · 87 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Development of a sensitive RT-PCR method for amplifying and sequencing near full-length HCV genotype 1 RNA from patient samples

Eileen Z. Zhang, Doug J. Bartels, J. Daniel Frantz et al. · Virology Journal · 2013 · 24 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17